Blueprint Medicines Corporation(BPMC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BPMC Blueprint Medicines Corporation

交易中 09-18 11:37:12 EDT

88.15

+1.64

+1.89%

最高88.66	最低86.23	成交量10.67万
今开86.70	昨收86.51	日振幅2.80%
总市值55.84亿	流通市值55.22亿	总股本6,335万
成交额933.19万	换手率0.17%	流通股本6,264万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BPMC","market":"US","secType":"STK","nameCN":"Blueprint Medicines Corporation","latestPrice":88.145,"timestamp":1726673827902,"preClose":86.51,"halted":0,"volume":106691,"delay":0,"floatShares":62643837,"shares":63345465,"eps":-3.340985,"marketStatus":"交易中","marketStatusCode":2,"change":1.635,"latestTime":"09-18 11:37:12 EDT","open":86.7,"high":88.66,"low":86.2344,"amount":9331864.87948,"amplitude":0.028038,"askPrice":88.19,"askSize":203,"bidPrice":88,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-3.340985,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1726689600000},"adr":0,"listingDate":1430366400000,"adjPreClose":86.51,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":86.51,"preClose":86.51,"latestTime":"17:39 EDT","volume":14206,"amount":1228963.93,"timestamp":1726609164137},"volumeRatio":0.563048,"impliedVol":0.4583,"impliedVolPercentile":0.1071},"requestUrl":"/m/hq/s/BPMC/wiki","defaultTab":"wiki","newsList":[{"id":"2457177394","title":"Blueprint Medicines Corporation盘中异动 股价大跌6.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457177394","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457177394?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:31","pubTimestamp":1722864665,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时31分，Blueprint Medicines Corporation股票出现异动，股价快速下跌6.90%。截至发稿，该股报90.05美元/股，成交量1.6144万股，换手率0.03%，振幅0.00%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Zevra Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Protara Therapeutics, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为977.99%、33.00%、13.54%，振幅较大的相关个股有Cue Biopharma, Inc.、Compass Therapeutics, Inc.、Compugen医疗，振幅分别为12.33%、12.19%、10.29%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213105941fe2d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213105941fe2d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0053671581.USD","BPMC","BK4505"],"gpt_icon":0},{"id":"2456842912","title":"Blueprint Medicines Corporation跌4.13% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2456842912","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456842912?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:32","pubTimestamp":1722605533,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时32分，Blueprint Medicines Corporation股票出现异动，股价大幅下挫4.13%。截至发稿，该股报96.15美元/股，成交量4.8466万股，换手率0.08%，振幅1.11%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Exicure, Inc.、Os Therapies Incorporated、Moleculin Biotech, Inc.涨幅较大，Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为268.79%、57.64%、17.90%，振幅较大的相关个股有Exicure, Inc.、Anew Medical Inc C/Wts 21/06/2029 、Coya Therapeutics, Inc.，振幅分别为22.02%、17.87%、14.08%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221321395780c66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221321395780c66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPMC","LU0053671581.USD","BK4505","BK4139"],"gpt_icon":0},{"id":"1109081349","title":"异动解读 | Blueprint Medicines公司股价大跌6.23% 财报数据或是主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1109081349","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109081349?lang=zh_cn&edition=full","pubTime":"2024-08-01 22:05","pubTimestamp":1722521151,"startTime":"0","endTime":"0","summary":"Blueprint Medicines公司(BPMC)今日盘中股价大跌6.23%,引发市场广泛关注。分析人士认为,公司最新季度财报数据可能是导致股价大跌的主要原因。\n\n财报显示,BPMC第一季度调整后每股亏损0.80美元,高于分析师平均预期的每股亏损1.29美元。尽管营收同比大增140%至1.3816亿美元,但仍低于华尔街预期的1.0358亿美元。\n\n不过,BPMC股价今年迄今仍上涨17.4%,机构投资者对其长期前景保持乐观。目前19家机构中,有68%给予买入评级,26%给予持有评级。分析师对BPMC未来12个月的目标股价中位数为125美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BPMC"],"gpt_icon":0},{"id":"2456438835","title":"Blueprint Medicines 公司报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2456438835","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456438835?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:31","pubTimestamp":1722519112,"startTime":"0","endTime":"0","summary":"   * Blueprint Medicines Corp   报告了截至1月底的季度调整后每股亏损80美分，高于去年同期的每股收益2.19美元。华尔街预期为每股亏损 1.53 美元至 1.07 美元。* Blueprint Medicines Corp公布的本季度每股收益为亏损80美分。* 该公司当季亏损 4999 万美元。* Blueprint Medicines Corp本季度股价上涨了0.5%，今年迄今为止上涨了17.4%。8月1日 - 预测变化   * 在过去三个月中，分析师的平均盈利预期上升了约 6.3%。华尔街对 Blueprint Medicines Corp 的 12 个月目标价中位数为 125.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","BPMC","LU0053671581.USD"],"gpt_icon":0},{"id":"2456480777","title":"Blueprint Medicines Corporation盘中异动 早盘急速跳水5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456480777","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456480777?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:30","pubTimestamp":1722519048,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日21时30分，Blueprint Medicines Corporation股票出现异动，股价急速下跌5.69%。截至发稿，该股报102.14美元/股，成交量10.9727万股，换手率0.18%，振幅0.47%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Immuneering Corporation、Renovaro Inc.、Estrella Immunopharma, Inc.涨幅较大，Immuneering Corporation、Cns Pharmaceuticals, Inc.、Neurosense Therapeutics Ltd.较为活跃，换手率分别为42.73%、36.81%、13.09%，振幅较大的相关个股有Proqr Therapeutics N.V.、Centessa Pharmaceuticals Plc、Neurosense Therapeutics Ltd.，振幅分别为6.22%、4.84%、4.59%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801213048aefcb551&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801213048aefcb551&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4139","BPMC","BK4505"],"gpt_icon":0},{"id":"2455964056","title":"Blueprint Medicines Corp   预计每股亏损1.29美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455964056","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455964056?lang=zh_cn&edition=full","pubTime":"2024-07-31 02:57","pubTimestamp":1722365838,"startTime":"0","endTime":"0","summary":"   * Blueprint Medicines Corp    将于8月1日公布截至2024年6月30日的财报，预计季度收入将有所增长。* 根据LSEG的数据，17位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司预计将实现79.9%的营收增长，从去年同期的5757万美元增至1.03575亿美元。* LSEG 的分析师平均预计 Blueprint Medicines Corp 每股亏损 1.29 美元。* 华尔街对 Blueprint Medicines Corp 的 12 个月目标价中位数为 125.00 美元，高于上一交易日的收盘价 110.34 美元。7月30日 - 以前季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BPMC"],"gpt_icon":0},{"id":"2455637143","title":"巴克莱银行将目标价从75美元上调至105美元适用于Blueprint Medicines Corporation。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455637143","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455637143?lang=zh_cn&edition=full","pubTime":"2024-07-29 18:16","pubTimestamp":1722248168,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4521","LU0106831901.USD","BK5152","LU0345777659.USD","BPMC","LU1791807156.HKD","LU0047473722.SGD","LU0053671581.USD","LU0345777147.USD","LU0550127509.SGD","LU1668664300.SGD","BARC.UK","BK4207","BK4505","BCS","LU0161305163.EUR","LU1078025761.USD","LU0964806797.USD","LU0047473722.EUR"],"gpt_icon":0},{"id":"2449709567","title":"Blueprint Medicines Corporation盘中异动 股价大涨5.13%报117.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449709567","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449709567?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:25","pubTimestamp":1720448700,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时25分，Blueprint Medicines Corporation股票出现波动，股价快速拉升5.13%。截至发稿，该股报117.43美元/股，成交量23.4079万股，换手率0.37%，振幅3.73%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为0.85%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222500aef87a7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222500aef87a7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0053671581.USD","BPMC","BK4505"],"gpt_icon":0},{"id":"2449770641","title":"奥本海默：维持Blueprint Medicines(BPMC.US)评级，由优于大市调整至优于大市评级, 目标价由114.","url":"https://stock-news.laohu8.com/highlight/detail?id=2449770641","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449770641?lang=zh_cn&edition=full","pubTime":"2024-07-08 20:50","pubTimestamp":1720443046,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BPMC","BK4505","LU0053671581.USD"],"gpt_icon":0},{"id":"2439857430","title":"Blueprint Medicines Corporation跌2.31% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2439857430","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439857430?lang=zh_cn&edition=full","pubTime":"2024-05-29 23:09","pubTimestamp":1716995378,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日23时09分，Blueprint Medicines Corporation股票出现异动，股价急速跳水2.31%。截至发稿，该股报100.00美元/股，成交量4.2175万股，换手率0.07%，振幅1.49%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体跌幅为1.09%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Mustang Bio, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Mustang Bio, Inc.、Scorpius Holdings, Inc.、Kintara Therapeutics, Inc.较为活跃，换手率分别为406.99%、97.68%、29.41%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Mustang Bio, Inc.、冠科美博，振幅分别为97.00%、50.08%、44.82%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529230938af8af0a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529230938af8af0a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPMC","BK4505"],"gpt_icon":0},{"id":"2437039384","title":"Blueprint Medicines——在Ayvakit的销售额超过里程碑之后贷款机构于5月22日资助了B批延期提取1.50亿美元的定期贷款","url":"https://stock-news.laohu8.com/highlight/detail?id=2437039384","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437039384?lang=zh_cn&edition=full","pubTime":"2024-05-24 20:16","pubTimestamp":1716552973,"startTime":"0","endTime":"0","summary":"Blueprint Medicines——在Ayvakit的销售额超过里程碑之后贷款机构于5月22日资助了B批延期提取1.50亿美元的定期贷款","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242016169ee2c5d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242016169ee2c5d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BPMC"],"gpt_icon":0},{"id":"2434869435","title":"Blueprint Medicines Corporation2024财年第一财季实现净利润89.14百万美元，同比增加168.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434869435","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434869435?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:19","pubTimestamp":1715357976,"startTime":"0","endTime":"0","summary":"3月31日，Blueprint Medicines Corporation公布财报，公告显示公司2024财年第一财季净利润为89.14百万美元，同比增加168.57%；其中营业收入为96.12百万美元，同比增加51.87%，每股基本收益为1.45美元。从资产负债表来看，Blueprint Medicines Corporation总负债7.28亿美元，其中短期债务87.15百万美元，资产负债比为1.43，流动比率为3.76。机构评级：截至2024年3月31日，当前有16家机构对Blueprint Medicines Corporation目标价做出预测，其中目标均价为118.12美元，其中最低目标价为75.00美元，最高目标价为168.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110019498af1a835&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110019498af1a835&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPMC"],"gpt_icon":0},{"id":"2433195283","title":"Leerink Partners：上调Blueprint Medicines(BPMC.US)评级，由低于大市调整至大市一致评级, 目标价由50.","url":"https://stock-news.laohu8.com/highlight/detail?id=2433195283","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433195283?lang=zh_cn&edition=full","pubTime":"2024-05-07 01:47","pubTimestamp":1715017640,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4505","BPMC"],"gpt_icon":0},{"id":"2432134921","title":"HC Wainwright & Co.：维持Blueprint Medicines(BPMC.US)评级，由买入调整至买入评级, 目标价由125.00美元调整至135.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432134921","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432134921?lang=zh_cn&edition=full","pubTime":"2024-05-04 04:25","pubTimestamp":1714767928,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Blueprint Medicines(BPMC.US)评级，由买入调整至买入评级, 目标价由125.00美元调整至135.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040425338b714e7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040425338b714e7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BPMC"],"gpt_icon":0},{"id":"2432139191","title":"HC Wainwright &amp; Co.：维持Blueprint Medicines(BPMC.US)评级，由买入调整至买入评级, 目标价由125.","url":"https://stock-news.laohu8.com/highlight/detail?id=2432139191","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432139191?lang=zh_cn&edition=full","pubTime":"2024-05-04 04:14","pubTimestamp":1714767264,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4505","BK4139","BPMC"],"gpt_icon":0},{"id":"2432908476","title":"Piper Sandler：维持Blueprint Medicines(BPMC.US)评级，由中性调整至中性评级, 目标价由78.","url":"https://stock-news.laohu8.com/highlight/detail?id=2432908476","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432908476?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:44","pubTimestamp":1714743883,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BPMC","BK4505"],"gpt_icon":0},{"id":"2432929117","title":"Needham：维持Blueprint Medicines(BPMC.US)评级，由买入调整至买入评级, 目标价由97.00美元调整至130.","url":"https://stock-news.laohu8.com/highlight/detail?id=2432929117","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432929117?lang=zh_cn&edition=full","pubTime":"2024-05-03 17:50","pubTimestamp":1714729811,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4505","BPMC"],"gpt_icon":0},{"id":"2432323949","title":"Blueprint Medicines 公司报告截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432323949","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432323949?lang=zh_cn&edition=full","pubTime":"2024-05-03 02:55","pubTimestamp":1714676152,"startTime":"0","endTime":"0","summary":"   * Blueprint Medicines Corp   报告了截至3月底的季度调整后每股收益1.40美元，高于去年同期的每股收益2.15美元。华尔街预期为每股亏损 1.80 美元至 1.46 美元。* Blueprint Medicines Corp公布的本季度每股收益为1.40美元。* 公司报告的季度净收入为 8914 万美元。* Blueprint Medicines Corp 的股价本季度迄今保持稳定，今年迄今上涨了 2.8%。5月2日 - 预测变化   * 在过去三个月里，分析师的平均盈利预期上升了约 3.7%。华尔街对 Blueprint Medicines Corp 的 12 个月目标价中位数为 113.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","BPMC"],"gpt_icon":0},{"id":"2432601696","title":"Blueprint Medicines Corporation盘中异动 股价大涨8.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432601696","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432601696?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:32","pubTimestamp":1714656759,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时32分，Blueprint Medicines Corporation股票出现波动，股价急速上涨8.43%。截至发稿，该股报102.86美元/股，成交量7.9334万股，换手率0.13%，振幅4.32%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为1515.37%、302.91%、83.03%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Zura Bio Limited C/Wts 、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为30.66%、22.07%、18.71%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050221323987cb11be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050221323987cb11be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BPMC","BK4505"],"gpt_icon":0},{"id":"2432635229","title":"Blueprint Medicines Corporation盘中异动 股价大涨5.23%报96.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432635229","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432635229?lang=zh_cn&edition=full","pubTime":"2024-05-02 03:00","pubTimestamp":1714590014,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日03时00分，Blueprint Medicines Corporation股票出现波动，股价快速上涨5.23%。截至发稿，该股报96.12美元/股，成交量39.1326万股，换手率0.62%，振幅5.53%。Blueprint Medicines Corporation股票所在的生物技术行业中，整体涨幅为2.35%。其相关个股中，Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Bioatla, Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1414.05%、1217.31%、267.12%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、99.53%、77.43%。Blueprint Medicines Corporation公司简介：蓝图医药公司是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502030014861ea95b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502030014861ea95b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BPMC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.blueprintmedicines.com","stockEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0747},{"period":"3month","weight":-0.1893},{"period":"6month","weight":-0.0393},{"period":"1year","weight":0.6576},{"period":"ytd","weight":-0.0621}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0158},{"period":"3month","weight":0.0266},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.2692},{"period":"ytd","weight":0.1846}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"蓝图医药公司于2008年10月14日在特拉华州成立，是一家生物制药公司，专注于改善患者的异常活化蛋白激酶基因组驱动的疾病定义的生命。该公司的做法是系统性和可重复鉴定激酶是基因组疾病定义驱动器和手艺的候选药物与治疗窗户，提供显著和持久的临床反应的患者。该公司正致力于几乎所有的努力研发，最初的市场开发，提高资本。该公司是受一些风险相似的其他早期阶段的公司，包括关键个人的依赖;需要开发商业上可行的药物;其他公司，其中有许多是更大和更好的资本竞争;并需要获得足够的额外资金，其药物的开发提供资金。如果公司无法筹集资金需要时或有吸引力的条件，这将被迫推迟，减少，消除或超出许可它的某些研究和开发项目或今后的商业化努力。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.056044},{"month":2,"riseRate":0.666667,"avgChangeRate":0.012381},{"month":3,"riseRate":0.777778,"avgChangeRate":0.045895},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.022821},{"month":5,"riseRate":0.7,"avgChangeRate":0.090385},{"month":6,"riseRate":0.6,"avgChangeRate":0.061595},{"month":7,"riseRate":0.7,"avgChangeRate":0.014145},{"month":8,"riseRate":0.7,"avgChangeRate":0.055409},{"month":9,"riseRate":0.6,"avgChangeRate":0.021868},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.024889},{"month":11,"riseRate":0.555556,"avgChangeRate":0.04614},{"month":12,"riseRate":0.555556,"avgChangeRate":0.045056}],"exchange":"NASDAQ","name":"Blueprint Medicines Corporation","nameEN":"Blueprint Medicines"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Blueprint Medicines Corporation(BPMC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Blueprint Medicines Corporation(BPMC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Blueprint Medicines Corporation,BPMC,Blueprint Medicines Corporation股票,Blueprint Medicines Corporation股票老虎,Blueprint Medicines Corporation股票老虎国际,Blueprint Medicines Corporation行情,Blueprint Medicines Corporation股票行情,Blueprint Medicines Corporation股价,Blueprint Medicines Corporation股市,Blueprint Medicines Corporation股票价格,Blueprint Medicines Corporation股票交易,Blueprint Medicines Corporation股票购买,Blueprint Medicines Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Blueprint Medicines Corporation(BPMC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Blueprint Medicines Corporation(BPMC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}